Molecular profiling in muscle‐invasive bladder cancer: more than the sum of its partsGottfrid Sjödahl, David M. Berman, Chelsea Jackson et al.|The Journal of Pathology|2019Cited by 89
Diagnostic and prognostic implications of a three‐antibody molecular subtyping algorithm for non‐muscle invasive bladder cancerChelsea Jackson, David M. Berman, Vanessa Freitas Bratti et al.|The Journal of Pathology Clinical Research|2021Cited by 23
Abstract 616: Performance of IHC3-Uro immunohistechemistry-based molecular subtyping in muscle-invasive bladder cancerCéline Hardy, David M. Berman, Chelsea Jackson et al.|Clinical Research (Excluding Clinical Trials)|2021Cited by 0
Podium Session 1: Prostate Cancer June 26, 2016 1050–1150D. Robert Siemens, Ronald Kodama, Henry Klotz et al.|Europe PMC (PubMed Central)|2016Cited by 0